Newsflash: FDA Approves the DexCom G4 for Pediatric Use

(Image courtesy DexCom)

The DexCom G4 continuous glucose monitor (CGM) received FDA approval for use in children 2-17 years. This is long-awaited good news!

In my opinion, FDA-approval in kids will mean less resistance by insurance companies to cover it…or at least I hope. It has been an integral part of our diabetes management toolkit for almost two years now.

From the press release:

“Dexcom, Inc., (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today that it has rece...